US researchers have discovered a biochemical signalling process that causes densely packed cancer cells to break away from a tumour and spread the disease elsewhere in the body. [ + ]

The city of Brisbane has become home to what is claimed to be the world's most advanced genomics sequencer. [ + ]

ANSTO, the Centre for Medical Radiation Physics at the University of Wollongong and the National Institute of Radiological Sciences (NIRS), Japan, have partnered to deliver advanced cancer treatment, based on carbon ion therapy. [ + ]

Japanese researchers have reported the effect of a particular type of monoclonal antibody on epilepsy in mice, with promising results. [ + ]

Dr Amali Mallawaarachchi has been awarded a grant by PKD Foundation Australia to support the development of an improved genomic diagnostic tool for individuals with kidney disease. [ + ]

Researchers have uncovered a novel mechanism behind excessive platelet production present in people with diabetes, placing them at increased risk of cardiovascular complications such as heart attack and stroke. [ + ]

The Australian Academy of Science has inducted 21 of Australia's best scientists for their outstanding contributions to science. [ + ]

Actinogen Medical has recruited and treated the first patient as part of its Phase II clinical trial of Xanamem, the biotech company's cortisol-blocking drug. [ + ]

Australian researchers have achieved a major breakthrough in the fight against advanced melanoma, giving hope to over 1800 Australians expected to die from the deadly disease this year. [ + ]

Trajan Scientific and Medical (Trajan) has expanded its organisational and global manufacturing footprint with the opening of a Penang Malaysia facility. [ + ]

Nominations for GSK's Award for Research Excellence are now open until 10 July 2017. [ + ]

Leaders from the Australian Nuclear Science and Technology Organisation (ANSTO), experts from Italy and clinicians from NSW recently met to explore how the full range of particle therapy treatments may be made available to Australians. [ + ]

Science and technology company Merck has developed a new genome editing tool that is said to make CRISPR more efficient, flexible and specific. [ + ]

The Australian National University (ANU) is inviting citizen scientists with an interest in astronomy to join a search for exploding stars called supernovae. [ + ]

Australian-listed, clinical-stage oncology company PharmAust has secured a new patent in Australia covering the use of its lead drug for non-cancer applications, including neurodegenerative diseases, diabetes and age-related disorders. [ + ]